Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-008682
Filing Date
2017-09-29
Accepted
2017-09-29 10:11:06
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2268023
2 filename2.htm EX-10 78215
3 filename3.htm EX-10 352562
4 GRAPHIC g431217g14o23.jpg GRAPHIC 89533
5 GRAPHIC g431217g19n51.jpg GRAPHIC 61540
6 GRAPHIC g431217g32y96.jpg GRAPHIC 128946
7 GRAPHIC g431217g41w64.jpg GRAPHIC 89429
8 GRAPHIC g431217g42o58.jpg GRAPHIC 116891
9 GRAPHIC g431217g58u08.jpg GRAPHIC 152991
10 GRAPHIC g431217g74a40.jpg GRAPHIC 63714
11 GRAPHIC g431217g74g36.jpg GRAPHIC 77357
12 GRAPHIC g431217g74p02.jpg GRAPHIC 120875
13 GRAPHIC g431217g78m75.jpg GRAPHIC 85825
14 GRAPHIC g431217g81r65.jpg GRAPHIC 66175
15 GRAPHIC g431217g96e78.jpg GRAPHIC 114750
  Complete submission text file 0000950123-17-008682.txt   4304028
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01690 | Film No.: 171109435
SIC: 2834 Pharmaceutical Preparations